Efficacy of Rituximab (Anti-Cd20) for Refractory Systemic Lupus Erythematosus Involving the Central Nervous System

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.2006.057885
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus

Turkish Journal of Haematology
Hematology
2012English

Rituximab Treatment Efficacy in Patients With Systemic Lupus Erythematosus Refractory to Standard Therapy in the Long-Term Follow-Up

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2014English

A Neuroimaging Follow Up Study of a Patient With Juvenile Central Nervous System Systemic Lupus Erythematosus

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Physical Therapy Combined With Corticosteroid Intervention for Systemic Lupus Erythematosus With Central Nervous System Involvement: A Case Report

Journal of Physical Therapy Science
Physical TherapySports TherapyRehabilitation
2014English

Rituximab in the Treatment of Extensive and Refractory Subacute Cutaneous Lupus Erythematosus

Anais Brasileiros de Dermatologia
Dermatology
2018English

Nervous System Disease in Systemic Lupus Erythematosus: Current Status and Future Directions

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Systemic Lupus Erythematosus

JAMA - Journal of the American Medical Association
Medicine
2011English

Systemic Lupus Erythematosus

Deutsche Medizinische Wochenschrift
Medicine
2005English

Systemic Lupus Erythematosus: Extent and Patterns of Off-Label Use of Rituximab for SLE

Nature Reviews Rheumatology
Rheumatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy